Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer
- 1 May 1994
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 39 (5) , 1007-1013
- https://doi.org/10.1007/bf02087552
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Trophic Effects of Unsulfated Cholecystokinin on Mouse Pancreas and Human Pancreatic CancerPancreas, 1992
- Effects of Pancreastatin (24–49) on Growth of Normal Pancreas and Pancreatic CancerPancreas, 1991
- CCK stimulates growth of six human pancreatic cancer cell lines in serum-free mediumRegulatory Peptides, 1991
- Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990Digestive Diseases and Sciences, 1990
- CCK antagonists interact with CCK-B receptors on human small cell lung cancer cellsPeptides, 1990
- CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogsRegulatory Peptides, 1987
- Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cellsProceedings of the National Academy of Sciences, 1980
- Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreasInternational Journal of Cancer, 1975
- Hormonal Control of Pancreatic GrowthJournal of Clinical Investigation, 1973